Boston Scientific to buy Smart Therapeutics
This article was originally published in Clinica
Executive Summary
In its seventh company acquisition this year to date, Boston Scientific has exercised an existing option to buy Smart Therapeutics, which develops devices for intracranial therapies. Boston has spent the year busily making niche acquisitions to complement and expand its existing businesses.